Paul Freiman

Paul Freiman

Directeur/Membre du Conseil chez STABLECOIN DEVELOPMENT CORPORATION

Fortune : 262 $ au 31/05/2026

92 ans
Health Technology
Health Services
Technology Services

Profil

Paul E.
Freiman
is the founder of Third Age Pharma LLC, founded in 2009, serving as President.
Dr. Freiman is also the founder of Impressions Holdings LLC..
Dr. Freiman is currently an Independent Director at NovaBay Pharmaceuticals, Inc. since 2025 and a Director at Phytos, Inc. Former positions include President, Chief Executive Officer & Director at Neurobiological Technologies, Inc. from 1997 to 2009; Co-Chief Executive Officer at TAO Synergies, Inc. in 2014; Chairman & Chief Executive Officer at Syntex Corp.
from 1989 to 1994; Chairman at Penwest Pharmaceuticals Co. from 1997 to 2010; Chairman at Neurotrope, Inc. from 2014 to 2016; Chairman at Digital Gene Technologies, Inc.; Chairman at Pharmaceutical Research & Manufacturers of America; Chairman at UCSF Foundation; Chairman at United Way Silicon Valley; Chairman at Pharmaceutical Manufacturers Association of America; Director at NeoPharm, Inc. from 2004 to 2011; Director at Calypte Biomedical Corp.
from 1997 to 2009; Director at NovaCal Pharmaceuticals, Inc. from 2001 to 2002; Non-Executive Director at SciGen Pte Ltd.; Director at OMware, Inc.; Director at Otsuka America, Inc.; Director at Otsuka America Pharmaceutical, Inc.; Director at InSys Therapeutics, Inc. in 2011; Director at INSYS Therapeutics, Inc. in 2010; Non-Executive Director at Chronix Biomedical, Inc. from 2009 to 2021.
Education includes undergraduate studies at Fordham University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 206 ( 0 % ) 262 $ 31/05/2026

Postes actifs de Paul Freiman

SociétésPosteDébut
STABLECOIN DEVELOPMENT CORPORATION Directeur/Membre du Conseil 16/10/2025
Phytos, Inc.
Directeur/Membre du Conseil -
Fondateur 02/07/2010
Fondateur -

Anciens postes connus de Paul Freiman

SociétésPosteFin
Directeur/Membre du Conseil 01/04/2021
NEUROTROPE, INC. Directeur Général 12/09/2014
SYNAPTOGENIX, INC. Directeur Général 12/09/2014
Directeur/Membre du Conseil 02/05/2011
Directeur/Membre du Conseil 02/05/2011
Voir l'expérience en détail de Paul Freiman

Formation de Paul Freiman

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

59

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Technology Services

Electronic Technology

Consumer Services

Health Technology

Health Technology

Miscellaneous

Health Technology

Health Technology

Phytos, Inc.

Health Services

Pharmaceutical Manufacturers Association of America

Commercial Services

Health Technology

Technology Services

Commercial Services

  1. Bourse
  2. Insiders
  3. Paul Freiman
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇